White Paper

What Pharmacies Often Miss In USP <800> Compliance

GettyImages-1087219526-scientist-computer-screen-compliance-sterilization

Achieving true compliance with USP <800> standards requires a fundamental shift from equipment procurement to comprehensive system design. A common industry misconception is that installing a high-quality containment isolator automatically fulfills regulatory demands; however, surveillance data indicate that surface contamination can persist even in facilities with dedicated engineering controls. Because hazardous drug exposure risks are cumulative and extend across the entire lifecycle—from receipt and storage to compounding and disposal—protection cannot rely on a single device alone.

Ultimate safety depends on a multi-layered strategy that seamlessly integrates primary barriers with secondary engineering controls, such as strict room pressure relationships and specialized HVAC workflows. Furthermore, physical controls must be reinforced by rigid operational discipline, including validated cleaning protocols, meticulous personal protective equipment sequences, and continuous environmental monitoring to detect containment failures before exposure occurs. To understand how to bridge the gaps between equipment procurement and unified system integration, read the full analysis on optimizing facility-wide hazardous drug safety.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online